Oncology

All articles by Oncology

To close cancer gaps, AstraZeneca and NHL skate to where the puck is going

Marc Iskowitz

February 14, 2024

10:25 am

AstraZeneca teamed up with the NHL on a public health initiative to raise awareness of the need for timely screening and care.

GSK reports positive news on trio of high-profile products

Marc Iskowitz

February 7, 2024

11:53 am

Encouraging developments included an opportunity to build on the blockbuster debut of GSK’s RSV vaccine and the potential return of a previously withdrawn cancer drug.

Gilead invests $320M in Arcus to increase stake to 33%

Marc Iskowitz

January 31, 2024

4:28 pm

The pharma giant bolstered its board presence and invested another $320 million in Arcus, as part of an amended agreement between the two firms.

AstraZeneca teams with generative AI biologics firm to develop cancer drug

Marc Iskowitz

December 4, 2023

2:49 pm

The deal, which includes an upfront commitment from AstraZeneca as well as funding and milestone payments, marks the latest sign of Big Pharma’s confidence in AI-fueled R&D.

AbbVie to acquire ADC manufacturer ImmunoGen for $10.1B in oncology play

Jack O'Brien

November 30, 2023

11:06 am

The ImmunoGen deal, which is expected to close in the middle of 2024, is also estimated to be accretive to AbbVie’s diluted earnings per share beginning in 2027.

Gilead Oncology’s brand refresh takes back the possibilities cancer steals

Lecia Bushak

November 20, 2023

4:24 pm

Gilead Oncology’s brand refresh takes back the possibilities cancer steals.

Mural Oncology spins out from Alkermes with $275M, lead immunotherapy program

Marc Iskowitz

November 16, 2023

11:58 am

The spinoff between Mural and Alkermes created two pure-play companies.

Amgen unveils Partners of Choice oncology network

Lecia Bushak

September 21, 2023

1:30 pm

Amgen Partners of Choice will comprise eight medical institutions worldwide, including the Dana-Farber Cancer Institute in Boston and Gustave Roussy in Paris.